Tenaya Therapeutics Receives Orphan Drug Designation for Genetic Hypertrophic Cardiomyopathy Gene Therapy

https://www.tenayatherapeutics.com/tenaya-therapeutics-receives-orphan-drug-designation-and-presents-pre-clinical-data-for-its-most-advanced-gene-therapy-product-candidate-for-genetic-hypertrophic-cardiomyopathy/
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.